Oncomatryx receives the Banco Santander and Spanish Chamber of Commerce Innovation Award from the King
February 20, 2026
No Comments
News and Publications
NEWS
A Spanish drug offers new hope to patients with metastatic cancer
November 20, 2025
No Comments
Oncomatryx Biopharma Awarded Prestigious EIC Accelerator Funding to Advance Groundbreaking ADCs
July 14, 2025
No Comments
ONCOMATRYX raises €25 Million to foster OMTX705 Clinical Trials
January 15, 2025
No Comments
EVENTS
PUBLICATIONS
- Fabre M. et al. OMTX705, a Novel FAP-Targeting ADC demonstrates Activity in Chemotherapy and PD1-Resistant Solid Tumors Models. Clin Cancer Res. 2020.26(13):3420-3430. DOI: 10.1158/1078-0432.CCR-19-2238
- Pascual-Antón L. et al. Targeting carcinoma-associated mesotelial cells with antibody-drug conjugates in ovarian carcinomatosis. J. Pathol. 2023. 261(2):238-251. DOI: 10.1002/path.6170
- Puerto-Camacho P. et al. Preclinical Efficacy of Endoglin- Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma. Clin Cancer Res. 2019. 25(7):2228-2240. DOI: 10.1158/1078-0432.CCR-18-0936